Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huttunen

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|October 20, 2022
Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and AutoimmunityJulie A Spicer, Kristiina M Huttunen, Jiney Jose, et al.
Molecular Pharmaceutics|June 11, 2019
Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular TargetsElena Puris, Mikko Gynther, Elizabeth C M de Lange, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2006
High dietary phosphate intake reduces bone strength in the growing rat skeletonMinna M Huttunen, Ilse Tillman, Heli T Viljakainen, et al.
Pharmaceutical Research|March 21, 2007
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionalityKristiina M Huttunen, Niina Mähönen, Jukka Leppänen, et al.
International Journal of Pharmaceutics|April 19, 2018
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptakeJussi Kärkkäinen, Mikko Gynther, Tarja Kokkola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2025
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitroWilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
Bioorganic Chemistry|May 2, 2021
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocationJussi Kärkkäinen, Tuomo Laitinen, Magdalena Markowicz-Piasecka, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2025
Corrigendum to "Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro" [European Journal of Pharmaceutical Sciences 215 (2025) 107322]Wilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
Molecular Pharmaceutics|May 29, 2024
Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport StudyEva Ramsay, Ahmed B Montaser, Kanako Niitsu, et al.
Bioorganic & Medicinal Chemistry|June 14, 2011
Inhibition of the cellular function of perforin by 1-amino-2,4-dicyanopyrido[1,2-a]benzimidazolesDani M Lyons, Kristiina M Huttunen, Kylie A Browne, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|October 20, 2022
Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and AutoimmunityJulie A Spicer, Kristiina M Huttunen, Jiney Jose, et al.
Molecular Pharmaceutics|June 11, 2019
Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular TargetsElena Puris, Mikko Gynther, Elizabeth C M de Lange, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2006
High dietary phosphate intake reduces bone strength in the growing rat skeletonMinna M Huttunen, Ilse Tillman, Heli T Viljakainen, et al.
Pharmaceutical Research|March 21, 2007
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionalityKristiina M Huttunen, Niina Mähönen, Jukka Leppänen, et al.
International Journal of Pharmaceutics|April 19, 2018
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptakeJussi Kärkkäinen, Mikko Gynther, Tarja Kokkola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2025
Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitroWilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
Bioorganic Chemistry|May 2, 2021
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocationJussi Kärkkäinen, Tuomo Laitinen, Magdalena Markowicz-Piasecka, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 23, 2025
Corrigendum to "Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro" [European Journal of Pharmaceutical Sciences 215 (2025) 107322]Wilma Kiander, Hatam Rashidpour, Mikko Gynther, et al.
Molecular Pharmaceutics|May 29, 2024
Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport StudyEva Ramsay, Ahmed B Montaser, Kanako Niitsu, et al.
Bioorganic & Medicinal Chemistry|June 14, 2011
Inhibition of the cellular function of perforin by 1-amino-2,4-dicyanopyrido[1,2-a]benzimidazolesDani M Lyons, Kristiina M Huttunen, Kylie A Browne, et al.
Pageof 16